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INTRODUCTION 
Asthma is a heterogeneous disease usually characterized by chronic airway 
inflammation which is defined by the history of respiratory symptoms like wheeze, 
shortness of breath, chest tightness and cough that vary over time and in intensity, 
together with variable expiratory airflow limitation. [1] 
These symptoms and airflow limitation characteristically vary over time and in 
intensity which are often triggered by factors such as exercise, allergen, and change in 
weather conditions or viral respiratory infections. They may resolve spontaneously or 
in response to medications but sometimes flares up resulting in life threatening 
exacerbations carrying significant burden to patients and the community. Asthma is 
usually associated with airway hyper responsiveness to either direct or indirect stimuli 
and with chronic airway inflammation. 
Asthma is a common disease whose prevalence has increased throughout the 
world for several decades. For many years the major focus of asthma investigations and 
treatment was on allergic mechanisms. More recently, studies of the epidemiology, 
natural history and pathogenesis have clearly demonstrated that asthma is a 
heterogeneous disease with multiple etiologies, contributing cofactors, complex 
pathobiologic mechanisms, and different molecular phenotypes.  
Understanding these differences is critical for developing various phenotypes of 
asthma that will be effective for better asthma management. 
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Fig 1: Symptoms of Asthma 
BURDEN OF ASTHMA 
 Asthma is one of the most common chronic diseases worldwide with an 
estimated 300 million affected individuals[2] 
 Prevalence is increasing in many countries, especially in children 
 Asthma is a major cause of school and work absence 
 Health care expenditure on asthma is very high [2] 
 Developed economies might expect to spend 1-2 percent of total health 
care expenditures on asthma   
 Developing economies likely to face increased demand due to increasing 
prevalence of asthma 
 Poorly controlled asthma is expensive 
 However, investment in preventive medication is likely to yield cost 
savings in emergency care 
PREVALENCE OF ASTHMA 
Asthma prevalence has been steadily increasing over time. Although a family 
history of allergy is the strongest risk factor for asthma, early life infections are 
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important cofactors. The increasing prevalence of asthma may relate to the success of 
domestic hygiene in reducing the rate of exposure to bacterial products or change in the 
commensal microbiome in early childhood, which would otherwise consolidate 
antibacterial rather than allergic immune responses.  
On the other hand, viral respiratory infections in early childhood are thought to 
increase the risk for wheezing illnesses and asthma over time. A range of other 
exposures have been identified as risk factors for asthma, including, diet, stress, 
exposure to farm products in childhood, second hand smoking,  obesity, air pollution, 
antibiotic use, aspirin use, exercise and occupational exposures. 
 
 
 
Fig 2: Prevalence of current asthma in United States 
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Fig 3: Estimated prevalence of asthma in children  
(13-14 years) 
 
 
 
Fig 4: Estimated worldwide prevalence of clinical asthma 
In 2012, current asthma prevalence was very high in black non-Hispanics 
(11.9%), those of Puerto Rican heritage (18.8%), and among those living below the 
poverty threshold (12.4%). Current asthma prevalence also was higher among children 
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(9.3%) than adults (8.0%) and among females (9.5%) than males (7.0%). The female-
to-male balance changes over development with asthma less common in females than 
males during childhood (age younger than 18, 8.6% vs. 10%, respectively) but more 
common in females than males during adulthood (age 18 or older, 9.8% vs. 6%, 
respectively) [3] 
 
Fig 5: Current asthma prevalence in US by age, gender, ethnic groups and 
income 
 
RISK FACTORS OF ASTHMA 
ALLERGY 
The strongest risk factor for asthma is a family history of atopy [4][5]. This 
increases the risk of developing allergic rhinitis by fivefold and the risk of asthma by 
threefold to fourfold [6].  In children 3 to 14 years old, both positive skin tests and 
increases in total serum IgE are strongly associated with asthma [7][8]. Serum IgE also 
correlates strongly with bronchial hyper responsiveness [9]. In adults, the odds of having 
asthma increase with the number of positive skin tests to common allergens [10]. 
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Fig 6: Pathophysiology of atopy in asthma 
Allergic asthma is associated with sensitivity to allergens of the indoor 
environment and these allergens are considered as a primary cause of the rise of asthma 
in infancy and early childhood. Specific allergens of interest includes house dust 
mite[11][12], dog and cat dander [13] and cockroach allergens [14] 
      (a)                                                               (b) 
       
Fig 7: Causative agents in allergic asthma (a) Pollen dust (b) Dust mite 
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HYGIENE HYPOTHESIS 
The cause of increase in asthma and allergies in westernized countries is the 
“hygiene hypothesis”. This holds that the rise in allergies in children is an unintended 
consequence of the success of domestic hygiene in reducing the rate of infections or 
exposure to bacterial products in early childhood. This hypothesis was put forward to 
explain the inverse relationship between hay fever and family size [15].  
 
Fig 8: Immunology in hygiene hypothesis 
In these studies, children who lived on farms had a lower prevalence of hay fever 
and asthma than their peers who did not live in an agricultural environment. The 
reduction in risk was stronger for children whose families were running the farm on a 
fulltime basis, and stronger yet if the farm included livestock [16][17]. Factors related to 
environmental influences, such as increased exposure to bacterial compounds in stables, 
may prevent the development of allergic disorders in children. Continual long-term 
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exposure to stables until age 5 was associated with very low rates of asthma (0.8%), hay 
fever (0.8%), and atopic sensitization (8.2%) [18]. 
HUMAN MICROBIOME 
 One potential link between changes in hygiene and allergic disease is the effect 
that “improved” hygiene may have on our indigenous microbiota and the role this 
microbiota may play in shaping our immune system [19-23]. The biologic model most 
commonly cited to explain this association is that early-life exposure to factors that 
promote Th1 immunity are necessary to blunt exuberant type 2 T helper (Th2) 
immunity[24-32].  
 
Fig 9: Role of human microbiome in asthma  
RESPIRATORY VIRAL INFECTIONS 
 Viral respiratory tract infections play in the development of asthma [33]. Children 
who have lower respiratory tract infections (LRIs) caused by respiratory syncytial virus 
(RSV) are at a threefold to fourfold risk of subsequent wheezing during the early school 
years [34-37]. The association between viral LRIs and subsequent asthma depends on 
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concurrent atopic disease, suggesting that an interaction between atopic predisposition 
and LRI at an early developmental stage may be critically important [38]. 
 
Fig 10: Role of respiratory viral infections in asthma 
 
ATYPICAL BACTERIAL INFECTIONS 
 Two bacterial causes of “atypical” pneumonia have been implicated in the 
development of chronic wheezing illnesses, Chlamydia pneumoniae and Mycoplasma 
pneumoniae. They are associated with an increase in the tissue mast cells and these 
atypical infections are associated with asthma exacerbations [39][40]. Both organisms are 
sensitive to macrolide antibiotics, and several studies have evaluated the utility of 
macrolides in patients with chronic asthma with variable results. 
AIR POLLUTION 
 The role of air pollution in contribution to the development of asthma is still 
uncertain. It was widely accepted that air pollution can exacerbate pre-existing 
asthma[41][42]. It has been postulated that exposure of the lung to air pollution could 
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increase local oxidative stress, induce or modify local inflammation, enhance 
sensitization to allergens, impair lung development, or injure small airways. Several 
recent studies focused specifically on asthma incidence and prevalence by proximity to 
heavy automobile traffic and suggested that exposure to respirable particulate matter 
and NO2 in this setting are both associated with the future development of asthma[43-48]. 
 
 
Fig 11: Role of air pollution in asthma 
 
OCCUPATIONAL EXPOSURES 
Occupational exposures constitute an important risk factor for a specific subset 
of patients. Asthma induced by occupational exposures accounts for up to 17% of all 
adult-onset asthma [49]. Occupational asthma can either result from immunologically 
mediated sensitization to occupational agents (i.e., sensitizer-induced occupational 
asthma) or from exposure to high concentrations of irritant compounds (i.e., irritant-
induced occupational asthma) 
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Fig 12: Role of occupation in asthma 
PATHOGENESIS OF ASTHMA 
 
Fig 13: Pathophysiology of asthma 
18 
 
PHENOTYPING 
ASTHMA HETEROGENEITY 
Patients with asthma can have a great deal of heterogeneity with respect to 
severity of airflow limitation, symptoms, degree of reversibility, and therapeutic 
response. Up to 30% to 45% of asthmatics do not respond to high doses of inhaled 
corticosteroids (ICSs) with improvements in lung function [50][51].    
There is significant heterogeneity in asthma triggers, the frequency and severity 
of exacerbations, and long-term outcomes such as irreversible loss of lung function due 
to airway remodelling. 
Several approaches have been taken to assign asthmatics to distinct sub 
phenotypes. A better appreciation of disease heterogeneity at a molecular and cellular 
level will be important in treating severe asthma and in the clinical application of 
emerging asthma therapies.  
 
Fig 14: Schematic representation of various asthma phenotypes 
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CELLULAR PHENOTYPES 
 Analysis of sputum, bronchoalveolar lavage and endobronchial biopsy 
specimens from asthmatic patients had found that majority of asthmatics had elevated 
eosinophils [52]. Non-eosinophilia is seen in 25% of asthmatics [53]. In severe asthma, 
noneosinophilic type is seen and it is mainly associated with a lower FEV1, fewer mast 
cells and less sub epithelial fibrosis [54]. There are four categories of cellular 
classification of asthma based on induced sputum cytological analysis (1) eosinophilic, 
(2) neutrophilic, (3) mixed eosinophilic and neutrophilic, and (4) paucigranulocytic 
asthma, where there is no observable presence of inflammatory cells [55][56].  
CLINICAL PHENOTYPES 
 Cluster-based multivariate approaches, designed to overcome the limitations of 
using only one variable, such as severity of airflow obstruction or type of cellular 
inflammation had identified three distinct clusters in mild to moderate asthmatics: one 
with early-onset atopic asthma and eosinophilia; another with a preponderance of 
obesity, females, and lack of eosinophilia; and a third with mild disease and lack of 
airway eosinophilia [57]. 
MOLECULAR PHENOTYPES (ENDOTYPES) 
An alternative approach to clustering subjects with asthma is to group them on 
the basis of molecular pathways found to be active in individual patients. Creating 
subgroups based on the activity of specific cytokine pathways has the added advantage 
that it points to specific pharmaceutic targets and biomarkers for clinical trials. 
Subgroups of patients who share an underlying disease biology have been named 
“endotypes.”[58] 
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AIMS AND OBJECTIVES 
 
 
1. To study the epidemiology of bronchial asthma phenotypes in urban 
population of North Chennai. 
 
2. To assess the influence of environmental exposure on the prevalence and 
expressions of various phenotypes of bronchial asthma. 
 
 
 
 
 
 
 
 
 
 
 
 
 
21 
 
REVIEW OF LITERATURE 
Asthma is a complex disease which includes distinct phenotypes with different 
etiologies, natural histories and treatment responses. Asthma impacts significantly on 
the rising burden of chronic disease in the developing countries.  Approximately 5 to 
10% of patients have refractory asthma which was poorly controlled despite maximal 
inhaled therapy.  
Many distinct phenotypes had been identified based on a limited number of 
characteristics. Most common phenotypes includes the allergic and non-allergic asthma. 
Other phenotypes defined by clinical and physiological categories like severity, age at 
onset and chronic airflow obstruction, asthma triggers like exercise, allergens, 
occupational allergens or irritants or their pathobiology like eosinophilic or neutrophilic 
asthma had been proposed.  
The heterogeneity in the physiologic, pathologic and molecular abnormalities 
makes the effective clinical care more complicated. Thus identification of more distinct 
phenotypes of asthma would be possible by comprehensive examination protocol of 
asthma patients incorporating several domains of the disease. This kind of 
characterization of asthma would allow a better understanding of the aetiology of 
asthma and by detecting the environmental and genetic risk factors. Poor coherence and 
individual subjectivity limits the current description of asthma phenotypes.  
Incorporation of multidimensionality of asthma in identifying the subgroups 
with consistent pattern of the disease provides a framework for identifying distinct 
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phenotypes with specific abnormalities that predict response to particular therapies 
focussing the current genetic and molecular studies. 
The aim of the present study is to identify distinct asthma phenotypes for use in 
aetiological studies and towards a personalised treatment of asthma. 
ASTHMA WITH OBESITY 
The prevalence of asthma and obesity had increased substantially in recent 
decades in many countries which had led to a state that obese persons might be at 
increased risk of asthma development. In adults many studies had been done which 
were consistent with the role of obesity in the pathogenesis of asthma. The incidence of 
obesity has also been positively associated with obesity. Asthma comprises diverse 
phenotypes reflecting heterogeneity in a number of characteristics associated with 
obesity. Obesity is associated with increased prevalence of asthma especially in women 
and appears to be more severe in the obese.  
In a study conducted by Andrea Lessard et al, 44 consecutive obese subjects 
(BMI≥30 kg/m2) and 44 consecutive non-obese subjects (BMI<25 kg/m2) al with 
asthma were included in study. The asthma control was poorer in obese subjects than in 
non-obese subjects (P=0.005). They concluded that obese people with asthma had 
poorer asthma control than the non-obese asthmatics despite similar symptoms 
perception. Such bronchial and systemic characteristics and the specific pattern of 
pulmonary function changes suggested a different phenotype of asthma in these obese 
subjects [59]. 
Another study by Beuther et al, A Meta-analysis of Prospective Epidemiological 
Studies, relationship between BMI and incident of asthma was studied and the impact 
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of sex was evaluated. Data was analysed by inverse-variance weighted, random effects 
meta-analysis. Stratified analysis between BMI categories and sex was performed. The 
results were of that when compared with normal weight, overweight and obesity showed 
increased odds of incident asthma with odds ratio of 1.51. They concluded that 
overweight and obesity were associated with a dose dependent increase in the odds of 
incident asthma in men and women and suggested that asthma incidence could be 
reduced by intervention targeting overweight and obesity [60]. 
In a study done by Holguin et al, they compared the associations between BMI 
and clinical parameters across age of onset phenotypes and to compare the rate of BMI 
change in relation to asthma duration by age of onset phenotypes. Multivariate logistic 
regression analysis was done to evaluate the association. In a study population 
consisting of 1049 subjects, the median age of onset was 10 years(interquartile range of 
4-25 years); 48% had late onset asthma (≥12 years) and 52% had early onset asthma 
(<12 years). Compared to obese subjects with late onset asthma, obese subjects with 
early onset asthma had more airway obstruction and recurrent admissions. They 
concluded that the asthma subjects were affected differently by obesity and the results 
highlighted the need to understand obesity as a co-morbidity that affects specific clinical 
phenotypes and not all asthma subjects are alike [61]. 
In a study done by Camargo et al, they performed a prospective cohort study of 
female nurses in the Nurses’ Health Study II, the main outcome measure was self-report 
of physician-diagnosed asthma with recent use of an asthma medication. They found 
1596 incident cases of asthma. In a multivariate model controlling for 9 potential 
confounding factors (including age, race, smoking, physical activity, and energy 
intake), the relative risks of asthma for 6 increasing categories of BMI in 1991 were 0.9, 
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1.0 (reference), 1.1, 1.6, 1.7, and 2.7 (P for trend <.001). Stronger associations were 
found using stricter definitions for asthma, and the finding was present in a variety of 
subgroups. In analyses controlling for the same variables, as well as BMI at age 18, 
women who gained weight after age 18 were at significantly increased risk of 
developing asthma during the 4-year follow-up period (P for trend <.001). They 
concluded that BMI has a strong, independent, and positive association with risk of 
adult-onset asthma. The increasing prevalence of obesity in developed nations may help 
explain concomitant increases in asthma prevalence [62]. 
AGE OF ONSET IN DETERMINING ASTHMA PHENOTYPE 
Age of asthma onset is often used to distinguish different adult asthma 
phenotypes but however similarities and differences between early and late onset adult 
asthma have not been summarized till date.  
In a study done by Tan et al, they found 12 studies comparing early and late onset 
asthma and age 12 was most commonly used to delineate the two age of onset 
phenotypes. Atopy was more likely associated with adults with early onset asthma and 
also higher frequency of asthma attacks. And adults with late onset asthma were mostly 
female, smokers and increased levels of spirometrically defined fixed airflow 
obstruction. They concluded that distinct phenotypic differences were found in relation 
to the age of asthma onset. Although early onset asthma was more likely attributed to 
atopy and potential genetic factors, late onset adult asthma appears to be more related 
to environmental risk factors and better targeted by preventive strategies [63].  
Although asthma is usually considered to originate in childhood, adult-onset 
disease is being increasingly reported in recent years. In a cohort study done by Akshay 
Sood et al, titled Adult-onset asthma becomes the dominant phenotype among women 
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by age 40, they studied the adult and paediatric onset asthma phenotypes using a three-
way analysis of covariance model and found out that the asthma of adult onset became 
the dominant (>50%) phenotype in women by 40 years and it was further lowered for 
obese, non-atopic group. They concluded that the studies of the differences between 
paediatric and adult onset asthma might provide greater insight into the phenotypic 
heterogeneity of asthma [64]. 
In a study done by Christina Miranda et al, they did a cross sectional analysis of 
integrated clinical, physiologic and pathologic data collected from 80 subjects with 
severe asthma. The subjects were divide into 2 groups, one with asthma onset before 
age 12 years (n=50) and second group with onset after age 12(n=30) and with the 
presence or absence of lung eosinophils. The results came as those subjects with early 
onset, severe asthma had significantly more allergen sensitivity (skin test positivity, 
98% vs 76%, P<0.007) and more allergic symptoms (P values ≤ 0.02) than subjects with 
late onset asthma. In contrast, subjects with late onset asthma had lower lung function 
than early onset despite a shorter duration of illness. Both groups had high degree of 
asthma symptoms and those with high eosinophils had lower lung function and only the 
early onset asthmatics presented with lymphocytic or mast cell inflammatory process. 
They concluded that differentiating asthma by age of onset and presence or absence of 
eosinophils identifies the phenotypes of asthma [65]. 
In another study done by Valerie Siroux et al, they assessed the relationship of 
eosinophils, IgE and atopy with asthma according to gender and age of onset. Data was 
obtained from the Epidemiological study on the Genetics and Environment of Asthma, 
Bronchial Hyper responsiveness and Atopy. Adults and children with asthma recruited 
in chest clinics (n = 313) and 1st degree relatives of patients with asthma (n = 214) were 
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compared with non-asthmatic controls (n = 334) and first-degree relatives without 
asthma (n = 595). They found that in women, eosinophilia was significantly associated 
with perimenstrual asthma independent from age, smoking and asthma severity 
(eosinophil/mm3 330 vs 194; p=0.01). In non-asthmatic women, IgE was significantly 
decreased and atopy decreased. Considering both the genders, the increase in the 
eosinophil count with asthma was significantly greater in women with childhood onset 
asthma than in women with adulthood onset or in men. No interaction between gender 
and asthma was observed for eosinophils in children [66]. 
FAMILY HISTORY OF ASTHMA AND ITS INFLUENCE ON 
OFFSPRINGS 
Family history of asthma and allergies had also played a significant role in the 
risk of developing asthma in childhood. Although heredity plays a major role in asthma 
and other allergic diseases, mechanisms underlying the pattern of inheritance of these 
disorders were poorly understood as well as the relative contribution of maternal and 
paternal conditions to the risk of the disease. Many studies had been shown that the 
family history of asthma and allergy increased the risk of asthma in childhood. Based 
on the prospective birth cohort, Martinez et al had proposed that parental history of 
asthma and allergy related more strongly to early onset asthma that persists later into 
childhood.  
A cross sectional study was conducted by London et al analysing the relation 
between family history and the types of asthma and found out that for children with two 
asthmatic parents, the prevalence ratio for early onset persistent asthma was 12.1 when 
compared with 7.51 for early onset transient asthma and 5.38 for late onset asthma. 
They concluded that that the parental history of asthma and allergy was most strongly 
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associated with early onset persistent asthma. They suggested that in children who are 
genetically predisposed and who an early environmental exposure and maternal 
smoking during pregnancy had developed early onset asthma that persists into early 
childhood [67]. 
Another study done by Litonjua et al they investigated the maternal and paternal 
asthma, eczema and hay fever as cross sectional predictors of childhood asthma and 
allergic disease in 306 children with median age of 3.5 years from families in which at 
least  one parent had a history of either asthma or other allergic conditions. The results 
were that for asthma in particular, maternal asthma was most strongly associated with 
asthma in child of all ages in both univariate (OR=3.2) and multivariate (OR=4.1) 
models. Among children <5 year, the risk of childhood asthma associated with maternal 
asthma was greater (OR-5.0) than the risk associated with paternal asthma (OR=1.6) 
where as both maternal asthma and paternal asthma were associated with similar risks 
among the children ≥5 year of age (OR=4.6 and OR-4.1 respectively). They concluded 
that the odds of having asthma in child was 3 times greater in families with one 
asthmatic parent and 6 times greater in families with two asthmatic parents. Also 
inhalant allergy in one parent had also conferred additional risk in the presence of 
asthma in other parent [68]. 
In a study done by Mutius et al, they investigated school children (n=9403), 9-
11 years of children were enrolled in a cross sectional survey. The prevalence of asthma 
and allergic diseases in parents and children were assessed by a parental questionnaire. 
Atopic sensitization was measured by skin prick tests, and bronchial responsiveness 
was determined by cold air hyperventilation challenge. The prevalence of asthma alone 
increased strongly if nearest of kin suffered from asthma alone (4.7 versus 11.7%, 
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P=0.0001). They concluded that the results strongly suggested a separate genetic factor 
controlling the development of asthma [69]. 
Another study done by Lim et al, they had screened the medical literature from 
1966 to 2009 and performed a meta-analysis to compare the effect of maternal asthma 
vs. paternal asthma on susceptibility of asthma in offspring. Consolidating the data from 
33 studies, the odds ratio for asthma in children of asthmatic mothers compared with 
non-asthmatic mothers was significantly increased at 3.04. The corresponding odds 
ratio for asthma in children of asthmatic fathers was increased at 2.44. When comparing 
the odds ratios, maternal asthma conferred greater risk of disease than did paternal 
asthma (3.04 vs. 2.44, p = 0.037). The concluded that in all cases the maternal asthma 
was a greater risk factor for asthma than paternal asthma [70]. 
In a study done by Davis et al, they examined the relationship between atopy and 
wheeze among children and their possible influence on the parental atopy and family 
size. The prevalence of wheeze was 15.5% in boys, 7.6% in girls and of atopy 19.7% in 
boys and 8.1% in girls. Of 110 atopic children 70% had no atopic parents whereas 27% 
had one atopic parent and in about 3% both parents were atopic. The presence of atopy 
in parents was associated with an increased prevalence of wheeze in boys but not in 
girls. Prevalence of wheeze among boys was 27.5% if either or both the parents were 
atopic against 12% with no parental history of atopy (P<0.05). They concluded that 
there was a strong association between parental atopy and wheeze in children [71]. 
ASTHMA PREVALENCE, FAMILY SIZE AND BIRTH ORDER 
The association between the family size and the prevalence of asthma had been 
a subject of considerable study and remained a matter of controversy. Many studies had 
found a negative correlation between asthma prevalence and family size. In contrast one 
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study detected a higher asthma prevalence in larger families while some had found no 
association between two. Broad implications of the protective mechanism of the sibling 
were explained in various theories. One of the leading theory, “hygiene hypothesis” had 
predicated that exposure to bacterial components had protected children from asthma. 
It is probably through an effect on the relatively immature immune system of the early 
childhood, thereby preventing the proclivity towards atopy. The theory suggested that 
the presence of older siblings increased the child’s exposure to bacterial burden and as 
a result, a higher degree of protection was anticipated in younger siblings as they are 
exposed to more children at home during childhood.  
In a study done by Goldberg et al, they examined the relationship of asthma with 
family size and birth order. Odds ratios for asthma and between birth order and family 
size, adjusted for each other, were calculated. The prevalence of asthma among males 
was 8.6% and among girls was 6.9%. The prevalence of asthma was inversely related 
to the number of children in the family (P<0.001). Among subjects who are the only 
child in the family, the prevalence was 7.3%. The prevalence increased to 8.95% among 
subjects from families with 3 siblings. Also the prevalence decreased progressively as 
the number of siblings increased and reached a trough of about 0.58% in families of 15 
to 20 siblings. The prevalence of asthma was similar among all birth orders. They 
concluded that the prevalence of asthma was inversely proportional to number of 
children in families with four or more children and it is similar to all birth orders. It 
challenges the hygiene hypothesis as the mechanism of decreased asthma prevalence in 
large families [72]. 
In a study done by Bernsen et al, they carried out their study to find out the 
independent relations of birth order and sibship size with the presence of asthma, allergy 
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and eczema. 700 families in Netherlands were selected in a retrospective study with 
index children born during the period from 1988 to 1990. They found out that children 
with higher birth order had a lower risk of allergy when compared with first-borns. 
Allergy including eczema also had a significant relation with birth order (P=0.01). For 
asthma, no clear relationship has been found. A non-significant relationship with 
sibship size was found for asthma (P=0.06). They had concluded that first born children 
in small sibship were more at risk than those with larger sibships and hence birth order 
is inversely related to the risk of allergy independent of the size of sibship [73]. 
In a study done by Karmaus et al, they reviewed the protective effects of having 
a higher number of siblings for the risk of atopic eczema, asthma wheezing, hay fever 
and allergic sensitization by collecting the review of literature from medline since 1965 
and identified 53 different studies. Among them 9 of 11 studies had reported an inverse 
relation with number of siblings for eczema, 21 of 31 studies had reported inverse 
association for asthma and wheezing and 14 of 16 studies had supported the protective 
effect of a higher number of siblings for allergic sensitization or IgE reactivity. The 
study had emphasised a theory that was based exclusively on epidemiological 
associations. They concluded that the research had not yet answered the question of 
causal factors explaining the sibling effect and the prevailing ‘hygiene hypotheses’ had 
failed to explain the findings adequately [74]. 
SMOKING RELATED BRONCHIAL ASTHMA 
The role of tobacco smoking in the development of bronchial asthma has always 
remained controversial. Many reviews had been in the view that smoking increases the 
risk of asthma. But there have been no association found between asthma and smoking. 
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Some studies had found that there was an increased risk among smoking males but not 
among females.  
Airway inflammation in asthma involves a very complex interaction of cell 
mediators, cytokines and chemokines. Immune and non-immunologic environmental 
factors are important triggers of bronchial asthma including cigarette smoking and 
second-hand smoke. Approximately 25% to 35% of individuals with asthma are current 
smokers. It has been documented that smoking or exposure to SHS among asthmatics 
had increased asthma related morbidity and severity of the disease.  
 In an epidemiological study of bronchial asthma and smoking done by Flodin et 
al, they compared 79 cases of asthma who were diagnosed between 20 and 65 years of 
age with 304 randomly drawn population controls of similar age from the same area. 
The study mainly involved in comparing the questionnaire information on smoking 
habits, occupational exposures, dwelling conditions, various suspect allergen exposure 
and atopy. They found that those who had smoked for 3 years or more were at increased 
risk for bronchial asthma (OR=1.9). The relative risk estimate had not changed even 
after adjustment by multiple logistic regression for age and gender. They had finally 
concluded that the exposure to environmental tobacco smoke or passive smoking at 
work had involve a slightly greater risk in the development of bronchial asthma [75]. 
 In a study done by Siroux et al, they evaluated the role of smoking as a potential 
risk factor, selection factor and modifying factor of asthma in the Epidemiological study 
on the Genetics and Environment of Asthma (EGEA). They had analysed 200 adult 
asthmatics, 265 non-asthmatic controls and 586 relatives of asthmatics and found that 
less smoking was not associated with asthma in childhood (OR=1.06 in males and 0.98 
in females) but smoker asthmatics quit more often than controls (OR=2.20 in males and 
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1.02 in females). Adult onset asthma was unrelated to ever smoking (OR=1.07 in males 
and 1.02 in females). In asthmatics, active smoking was associated with asthma 
severity. No clear pattern regarding the relationship of smoking habits with asthma was 
observed in first degree relatives. It was concluded that active smoking is not a risk 
factor for asthma in adulthood, but that smoking increases asthma severity [76]. 
In a study done by Sapleton et al, they found out that the disease control was 
poorer in asthmatic smokers than in asthmatic non-smokers. Maternal exposure has 
been found to have greater impact on asthma and asthmatic children exposed to multiple 
household smoke were at increased risk. They had concluded that cigarette smoking 
and second hand smoke in asthmatics had led to detrimental effects in patient outcomes 
and effectiveness of steroid therapy [77]. 
Another study done by Verlato et al, they had aimed to study the incidence of 
asthma as a function of smoking habits in adult population. During their study 145 new 
cases of asthma were observed with a cumulative incidence of 4.6%. The cumulative 
incidence of asthma did not significantly differ among never-smokers (4.6%), ex-
smokers (5.4%) and current smokers (4.4%) (P=0.641). In a multivariate analysis, the 
most important risk factor for the onset of asthma was allergic rhinitis (OR=4.0). When 
compared to never smokers, the risk of asthma onset was slightly increased in ex-
smokers (OR=1.28) but not in current smokers (OR=1.01). They concluded that, current 
smoking was not a risk factor for new onset asthma [78]. 
Although the occurrence of childhood asthma has been attributed to involuntary 
exposure to maternal smoking during the in utero period and to second hand smoke, 
few studies had investigated the role of active cigarette smoking on asthma onset during 
adolescence. In a study done by Gillliand et al, titled regular smoking and asthma 
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incidence in adolescents, they did a prospective cohort study among 2909 children and 
followed them annually. They had found that regular smoking was asoociated with 
increased risk of new onset asthma. Children who had reported smoking 300 or more 
cigarettes per year had a relative risk of 3.9 for new onset asthma compared with non-
smokers. They had concluded that regular smoking had increased the risk for asthma 
among adolescents especially for non-allergic subjects [79]. 
ASPIRIN INTOLERENT ASTHMA 
Aspirin intolerant asthma, a clinically distinct syndrome, is characterised by 
precipitation of asthma attacks following the ingestion of aspirin and other non-steroidal 
anti-inflammatory drugs (NSAIDS). Despite the name relates only aspirin, it has 
established that the affected persons were cross sensitive to all non-steroidal anti-
inflammatory drugs that inhibit cyclo-oxygenase enzymes. Clinical presentation begins 
in the third or fourth decade and follows a characteristic growth. It is frequently 
associated with development of chronic nasal congestion, anosmia, rhinorrhoea and 
nasal polyps. Usually NSAID triggers an acute asthmatic attack which gradually 
develops into bronchial asthma. Generally these attacks occur within one hour of aspirin 
ingestion followed by typical presentation of profuse rhinorrhoea, conjunctival irritation 
and flushing of the head and neck. Only handful of studies have been available 
worldwide that has provided the estimates of the prevalence of AIA that ranges from 1-
2% up to 20%. The exact prevalence of AIA remained uncertain for a long time. Thus 
a greater understanding of aspirin induced asthma is desirable as there is an increasing 
trend in over the counter analgesics for minor ailments and their ignorance in relating 
the asthma with those analgesics. 
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 In a study done by Vally et al, they surveyed three populations to establish the 
prevalence of AIA among the Australian asthmatics. A total of 1814 asthmatics from 
hospitals, Asthma Foundation were recruited to the study. They had found that the 
prevalence of AIA in the hospital and Asthma Foundation cohorts was found to be 
10.7% and 10.4% respectively. Univariate analysis in the Asthma Foundation cohort 
had indicated that AIA was associated with more severe asthma (OR=2.4), nasal 
polyposis (OR=3.19), atopy (OR=2.96), sulphite sensitivity (OR=3.97) and sensitivity 
to wine (OR=3.27). They had concluded that prevalence of respiratory symptoms 
triggered by aspirin/NSAID use was found to be 10-11% in patients with asthma and 
2.5% in non-asthmatics [80]. 
In another study done by Jenkins et al, they reassessed the prevalence of aspirin 
induced asthma and other issues related to the syndrome. They had restricted the review 
to respiratory responses to analgesics available without prescription. They had found 
that the prevalence of aspirin induced asthma was highest when determined by oral 
provocation testing (adults 21%; children 5%) than by verbal history (adults 3%; 
children 2%). Patients with aspirin induced asthma also showed cross sensitivity to 
doses of over the counter non-steroidal anti-inflammatory drugs but the incidence of 
cross reactivity to paracetamol was found to be only 7%. They concluded that aspirin 
induced asthma in adults was more prevalent than previously suggested and an oral 
provocation test should be performed when there is a clinical necessity to use aspirin or 
a non-steroidal anti-inflammatory drug and there is uncertainty about its safety [81]. 
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MATERIALS AND METHODS 
Primary Objectives: 
a. To study the epidemiology of bronchial asthma phenotypes in urban 
population of North Chennai. 
b. To assess the influence of environmental exposure on the prevalence and 
expressions of various phenotypes of bronchial asthma. 
Secondary Objectives: 
 The population of patients with individual asthma phenotypes are expressed in 
percentage.  
The patients with significant environmental exposure expressed as percentage 
were further correlated with individual phenotypes and its significance is calculated. 
Sample Size: 
 Sample size-250 
 Allowable alpha error-5%, confidence level of 95% and desired accuracy of 6% 
Subject selection: 
 Patients attending the thoracic medicine outpatient clinic in Government 
Thiruvotteeswarar Hospital of Thoracic Medicine (GTHTM) and Government Kilpauk 
Medical College (KMC) with symptoms suggestive of bronchial asthma are selected.  
 A patient is suspected to have asthma if he or she has any one of the following 
symptoms as advocated by Global Initiative for Asthma (GINA) guidelines 2015. 
 Wheeze, Shortness of breath (dyspnea), Chest tightness or Cough 
 Variable expiratory airflow limitation 
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 Symptoms often worse at night or in the early morning 
 Symptoms vary over time and in intensity 
 Symptoms are triggered by viral infections, exercise, and allergen 
exposure, changes in weather or exposure to irritants. 
INCLUSION CRITERIA 
 Patients aged more than 6 years but less than 60 years 
 Patients with Dyspnea, Wheeze, Chest tightness or cough 
 Patients with significant post-bronchodilator reversibility 
 Patient with no significant lung lesions 
EXCLUSION CRITERIA 
 Patients with Bronchiectasis, chronic bronchitis and emphysema 
 Patients with acute exacerbation of asthma 
 Patients who cannot perform spirometry 
 Patients with no significant post bronchodilator reversibility 
STUDY CENTRES: 
 The study was conducted at two tertiary care institutes that have outpatient 
clinics for patients with respiratory illnesses. 
 Government Kilpauk Medical College, Chennai. 
 Government Thiruvotteeswarar Hospital of Thoracic Medicine, Chennai. 
STUDY DESIGN: 
 The study was a descriptive cross sectional study 
 No specific intervention was carried out 
 No controls had been used in the study. 
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DATA COLLECTION: 
 The data of each patient was collected on a proforma specially designed for this 
study. 
 Demographic data 
 Occupation 
 Socio-economic status 
 Body Mass Index 
 Birth order 
 History of Allergy/Atopy 
 Presence of disease in family members 
 Exposure to farm products in childhood 
 Exposure to allergens, chemicals at workplace 
 History of sensitivity to Aspirin/NSAIDs 
 Exposure to Environmental Tobacco Smoke 
 Food habits 
 Family size 
 History of Recurrent Respiratory Tract infections 
 History of Gastro-esophageal reflux disorder 
 Changes in climatic conditions 
 History of Stress and Emotional conditions 
 Knowledge about the disease, diagnosis and mode of treatment 
 Sputum cytology 
 Absolute Eosinophil Count 
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DEMOGRAPHIC DATA 
 Demography (demos-people; graph-description) is the statistical study of 
populations which is very important in analyzing the dynamic living population. It 
encompasses the study of the size, structure and distribution of these populations and 
spatial and temporal changes in them.  
 In my study the demographic details collected include the name, age and gender 
of the patient and their habitat and level of education. 
SOCIO-ECONOMIC STATUS 
 Socioeconomic status (SES) is an economic and sociological combined total 
measure of a person's work experience and of an individual's or family's economic and 
social position in relation to others, based on income, education, and occupation.  
 Socioeconomic status is typically broken into three categories namely high SES, 
middle SES, and low SES.  
A composite measure that typically incorporates economic, social, and work status.  
o Economic status is measured by income.  
o Social status is measured by education, and  
o Work status is measured by occupation.  
o Each status is considered an indicator.  
These three indicators are related but do not overlap 
Socio-economic Status Scales in India: 
o Udai Pareek and G. Trivedi (1964) 
o Kuppuswamy scale 1962 
o B G Prasad classification proposed in the year 1961  
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The most widely used scale for urban population was devised by Kuppuswamy in 1976. 
It is a composite score of education and occupation of the head of the family along with 
monthly income of the family, which yields a score of 3-29. This scale classifies the 
study populations into high, middle and low SES. 
 
Fig 15: Modified Kuppuswamy Scale  
BODY MASS INDEX 
 The body mass index (BMI) or Quetelet index is a value derived from 
the mass (weight) and height of an individual. The BMI is defined as the body 
mass divided by the square of the body height, and is universally expressed in units of 
kg/m2. 
 The BMI is an attempt to quantify the amount of tissue mass (muscle, fat, and 
bone) in an individual, and then categorize that person as underweight, normal 
weight, overweight, or obese based on that value. 
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Patient’s body weight is measured to nearest 0.1 kg with subjects in light clothing 
and patients’ height is measured by asking them to stand barefoot with their backs and 
heels touching a vertical bar to the nearest 0.5 cm and BMI is calculated. Drawback of 
BMI is it does not assess changes in body composition. 
BMI NUTRITIONAL STATUS 
<18.5 Underweight 
18.5-24.9 Normal 
25-29.9 Overweight 
>30 Obese 
 
 
Fig. 16: Pictorial representation of BMI 
BIRTH ORDER 
 Birth order refers to the order a child is born, for example first born, second born 
etc. Birth order is often believed to have a profound and lasting effect on psychological 
development. 
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 Asthmatic patients who are enrolled in the study are enquired about their birth 
order and details are recorded. 
 
Fig 17. Birth order and susceptibility to atopy 
EXPOSURE TO ALLERGENS 
 An allergen is a type of antigen  that produces an abnormally vigorous immune 
response in which the immune system fights off a perceived threat that would otherwise 
be harmless to the body. An allergen is an antigen capable of stimulating a type-I 
hypersensitivity reaction in atopic individuals through  Immunoglobulin E (IgE) 
responses. 
Most common extrinsic allergens which is responsible for triggering asthma 
includes pollen, dust mites, moulds, animal dander and cockroaches. 
Subjects are asked about their specific symptom exacerbation after exposing to any of 
these triggering agents and the specific allergen to which they are sensitized are 
recorded. 
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EXPOSURE TO TOBACCO SMOKE AND SECOND HAND SMOKING 
 Tobacco smoke is one of the most common asthma triggers. Tobacco smoke—
including secondhand smoke—is unhealthy for everyone, especially people with 
asthma. Secondhand smoke is a mixture of gases and fine particles that includes, 
 Smoke from a burning cigarette, cigar, or pipe tip 
 Smoke that has been exhaled (breathed out) by someone who smokes 
 
Fig 18. Role of smoking in asthma 
Male patients who are asthmatics and included in the study are enquired about their 
smoking history and female asthmatics and children are enquired about the exposure to 
passive or second hand smoke in their living room and details were recorded.          
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STATISTICAL ANALYSIS 
 Statistical analysis was done using the Microsoft Excel and SPSS software with 
the help of a statistician. P value is used to assess the significance of correlation between 
variables. 
Pearson correlation is used to assess the strength of correlation between variables  
Pearson correlation: 
 > 0.5 - Strong correlation 
 0.3 to 0.5 - Moderate correlation 
 <0.3 - Weak correlation 
Chi-square Test: 
 Chi-square test is performed between two groups and its statistical significance 
is calculated. The chi-square (χ2) test of independence is used to test for a statistically 
significant relationship between two categorical variables. The term "degrees of 
freedom" is used to refer to the size of the contingency table on which the value of 
the Chi Square statistic has been computed 
 
P value is calculated using Excel CHITEST function: 
If P value ≤ 0.05 → statistically significant 
If P value > 0.05 → statistically insignificant 
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RESULTS 
AGE DISTRIBUTION OF THE STUDY SUBJECTS: 
About 65% of the study subjects with asthma were in the age group of 21 to 40 
years. Mean age (± S.D): 32.63 (9.93) years, Minimum: 10 years,   Maximum: 56 years. 
Table 1: Age distribution of the study subjects (n=250) 
Age group Frequency Percent 
10-20 years 31 12.4 
21-30 years 84 33.6 
31-40 years 78 31.2 
41-50 years 50 20.0 
51-60 years 7 2.8 
Total 250 100.0 
 
 
 Fig 19: Age distribution of the study subjects (n=250) 
0
5
10
15
20
25
30
35
10 - 20 years 21-30 years 31-40 years 41-50 years 51-60 years
12.4
33.6
31.2
20
2.8
AGE DISTRIBUTION
45 
 
GENDER DISTRIBUTION OF THE STUDY SUBJECTS: 
About 54% of the study subjects with asthma were females and 46% of the study 
population were males. 
Table 2: Gender distribution of the study subjects (n=250) 
Gender Frequency Percent 
Male 114 45.6 
Female 136 54.4 
Total 250 100.0 
 
 
FIG 20: Gender distribution of the study subjects (N=250) 
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DISTRIBUTION OF THE STUDY SUBJECTS ACCORDING TO LEVEL OF 
EDUCATION: 
 
About 64.8% of the study subjects were illiterates and 35.2% were literates. The 
reason of major proportion of the study population being illiterates is due to the poor 
quality of living of the people in north Chennai from where the majority of patients are 
coming to our OPD. 
Table 3: Distribution of the study subjects according to  
Level of education (n=250) 
 
Education Frequency Percent 
Illiterate 162 64.8 
Literate 88 35.2 
Total 250 100.0 
 
 
Fig 21: Distribution of the study subjects according to level of education (n=250) 
Illiterate, 162
Literate, 88
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DISTRIBUTION OF THE STUDY SUBJECTS ACCORDING TO SOCIO-
ECONOMIC STATUS: 
About 64% of the study subjects belonged to low socio-economic status. It also 
indirectly reflects the poor quality of living of the people of north Chennai who in 
majority of the proportion were lacking good quality of education and most of them are 
daily wagers.  
Table 4: Distribution of the study subjects according to  
Socio-economic status (n=250) 
Socio-economic status Frequency Percent 
Low  160 64.0 
Middle  90 36.0 
Total 250 100.0 
 
 
Fig 22: Distribution of the study subjects according to  
Socio-economic status (n=250) 
64%
36%
SOCIO-ECONOMIC STATUS
Low SES Middle SES
48 
 
DISTRIBUTION OF THE STUDY SUBJECTS ACCORDING TO BODY 
MASS INDEX: 
About 34% of the study subjects were overweight and 7% were obese. Among 
the obese, majority of the patients were of females and older age group. 
Table 5: Distribution of the study subjects according to  
Body mass index (n=250) 
Body mass index Frequency Percent 
Normal 145 58.0 
Overweight 87 34.8 
Obese 18 7.2 
Total 250 100.0 
 
 
Fig 23: Distribution of the study subjects according to  
Body mass index (n=250) 
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DISTRIBUTION OF THE STUDY SUBJECTS ACCORDING TO BIRTH 
ORDER: 
About 65% of the study subjects belonged to first birth order. Majority of the 
patients were of the lower order i.e. first born child in their family and the remaining 
were of higher order i.e. 2nd or successive child in their family.  
Table 6: Distribution of the study subjects according to birth order (n=250) 
Birth order Frequency Percent 
1st order 162 64.8 
2nd order and above 88 35.2 
Total 250 100.0 
 
 
Fig 24: Distribution of the study subjects according to birth order (n=250) 
 
 
65%
35%
BIRTH ORDER
1st order 2nd order and above
50 
 
DISTRIBUTION OF THE STUDY SUBJECTS ACCORDING TO AGE OF 
ONSET OF ASTHMA: 
About 76% of the study subjects had early age of onset of asthma. Major 
proportion of the study population had their asthma symptoms from early childhood 
and has recurrent exacerbations when they are prone to triggering factors 
Table 7: Distribution of the study subjects according to  
Age of onset of asthma (n=250) 
Age of onset Frequency Percent 
Early onset 191 76.4 
Late onset 59 23.6 
Total 250 100.0 
 
 
Fig 25: Distribution of the study subjects according to  
Age of onset of asthma (n=250) 
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DISTRIBUTION OF THE STUDY SUBJECTS ACCORDING TO HISTORY 
OF SMOKING: 
About 25% of the study subjects were smokers and 20.8% were non-smokers. 
54% of the study subjects were females and none of them were smokers and it is mainly 
due to the absence of influence of the westernized culture in our country. 
Table 8: Distribution of the study subjects according to  
History of smoking (n=250) 
History of smoking Frequency Percent 
Yes 62 24.8 
No 52 20.8 
Not applicable 136 54.4 
Total 250 100.0 
 
Table 9: Distribution of the study subjects according to exposure to  
Passive smoking (n=250) 
Exposure to passive 
smoking 
Frequency Percent 
Yes 111 44.4 
No 60 24.0 
Not applicable 79 31.6 
Total 250 100.0 
 
About 44% of the study subjects were exposed to passive smoking. These 44% 
of the patients comprises of mostly females and children who are constantly exposed to 
passive or second hand smoking in their households and they give positive history of 
worsening of symptoms when they are exposed to these kind of triggering factors. 
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DISTRIBUTION OF THE STUDY SUBJECTS ACCORDING TO HISTORY 
OF ATOPY: 
About 52.8% of the study subjects had history of atopy in some forms. There is 
relatively a high proportion of patients who gives a positive history of atopy. 
Table 10: Distribution of the study subjects according to  
History of atopy (n=250) 
History of atopy Frequency Percent 
Yes 132 52.8 
No 118 47.2 
Total 250 100.0 
 
 
Fig 26: Distribution of the study subjects according to  
History of atopy (n=250) 
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DISTRIBUTION OF THE STUDY SUBJECTS ACCORDING TO FAMILY 
HISTORY OF ASTHMA (HEREDITARY): 
About 52% of the study subjects had family history of asthma (hereditary). There 
is relatively a high proportion of patients who gave a positive history of presence of 
asthma in their family members. 
Table 11: Distribution of the study subjects according to  
Family history of asthma (Hereditary) (n=250) 
Family history Frequency Percent 
Yes 129 51.6 
No 121 48.4 
Total 250 100.0 
 
 
Fig 27: Distribution of the study subjects according to  
Family history of asthma (hereditary) (n=250) 
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DISTRIBUTION OF THE STUDY SUBJECTS ACCORDING TO 
HEREDITARY PATTERN: 
Out of 129 subjects who gave positive history of asthma in their family members, 
about 30% of the study subjects inherited asthma from their mother while 16% from 
their father and a significant proportion of subjects comprising about 5% of the patients 
had given positive history of asthma in both the parents. 
Table 12: Distribution of the study subjects according to hereditary pattern  
Hereditary pattern Frequency Percent 
Father 41 16.4 
Mother 76 30.4 
Both Father and Mother 12 4.8 
Not applicable 121 48.4 
Total 250 100.0 
 
 
Fig 28: Distribution of the study subjects according to hereditary pattern (n=250) 
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DISTRIBUTION OF THE STUDY SUBJECTS ACCORDING TO EXPOSURE 
TO ALLERGENS: 
Out of 132 subjects who gave history of atopy about 20.8% of the study subjects 
were exposed to food allergen while 13% and 12% were exposed to animals and 
environmental dust and a significant proportion of subjects constituting 6% were 
allergic to pollen dust.  
Table 13: distribution of the study subjects according to exposure to allergens  
 
 
 
Fig 29: distribution of the study subjects according to exposure to allergens  
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Allergen Frequency Percent 
Pollen Dust 16 6.4 
Environmental dust 31 12.4 
Food Products 52 20.8 
Animals 33 13.2 
Nil 118 47.2 
Total 250 100.0 
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DISTRIBUTION OF THE STUDY SUBJECTS ACCORDING TO HISTORY 
OF EXPOSURE TO ASPIRIN/NSAIDs: 
About 6% of the study subjects had exposure to aspirin. These proportion of 
patients gave positive history of exacerbation of asthma symptoms when they had 
ingestion of aspirin or NSAIDs for some form of illness. 
Table 14: Distribution of the study subjects according to history of exposure to 
aspirin/NSAIDs (n=250) 
Exposure to 
aspirin/NSAIDs 
Frequency Percent 
Yes 16 6.4 
No 234 93.6 
Total 250 100.0 
 
 
Fig 30: Distribution of the study subjects according to history of exposure to 
aspirin/NSAIDs (n=250) 
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DISTRIBUTION OF THE STUDY SUBJECTS ACCORDING TO FAMILY 
SIZE: 
About 63% of the study subjects belonged to small family size. Family size plays 
a role in the prevalence of asthma and in our study the prevalence of asthma is inversely 
proportional to the family size. 
Table 15: Distribution of the study subjects according to  
Family size (n=250) 
Family size Frequency Percent 
Small 158 63.2 
Large 92 36.8 
Total 250 100.0 
 
 
Fig 31: Distribution of the study subjects according to  
Family size (n=250) 
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DISTRIBUTION OF THE STUDY SUBJECTS ACCORDING TO HISTORY 
OF RECURRENT RESPIRATORY INFECTIONS (RRTI): 
About 60% of the study subjects had history of recurrent respiratory infections. 
Majority of the patients gives positive history to the presence of recurrent respiratory 
tract infections which exacerbates their symptoms. 
Table 16: Distribution of the study subjects according to history of recurrent 
respiratory infections (RRTI) (n=250) 
H/o RRTI Frequency Percent 
Yes 151 60.4 
No 99 39.6 
Total 250 100.0 
 
 
Fig 32: Distribution of the study subjects according to history of recurrent 
respiratory infections (RRTI) (n=250) 
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DISTRIBUTION OF THE STUDY SUBJECTS ACCORDING TO HISTORY 
OF GASTRO-ESOPHAGEAL REFLUX DISEASE (GERD): 
About 19% of the study subjects had history of gastro-oesophageal reflux 
disease. Majority of these subjects were females and are obese which shows the impact 
of GERD in asthma provocation. 
Table 17: Distribution of the study subjects according to history of gastro-
oesophageal reflux disease (GERD) (n=250) 
H/O GERD Frequency Percent 
Yes 47 18.8 
No 203 81.2 
Total 250 100.0 
 
 
Fig 33: Distribution of the study subjects according to history of gastro-
oesophageal reflux disease (GERD) (n=250) 
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DISTRIBUTION OF THE STUDY SUBJECTS ACCORDING TO 
SUSCEPTIBILITY TO WEATHER CHANGE: 
About 70% of the study subjects were susceptible to develop asthma due to 
weather change. Weather changes play an important role in exacerbation of asthma 
symptoms and it is evident from this study very well. 
Table 18: Distribution of the study subjects according to susceptibility to  
Weather change (n=250) 
Susceptibility to weather 
change 
Frequency Percent 
Yes 176 70.4 
No 74 29.6 
Total 250 100.0 
 
 
Fig 34: Distribution of the study subjects according to susceptibility to  
Weather change (n=250) 
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DISTRIBUTION OF THE STUDY SUBJECTS ACCORDING TO 
SUSCEPTIBILITY TO STRESS TO DEVELOP ASTHMA: 
About 30% of the study subjects were susceptible to develop asthma due to 
stress/emotional conditions. 
Table 19: Distribution of the study subjects according to susceptibility to  
Stress to develop asthma (n=250) 
Susceptibility to stress Frequency Percent 
Yes 72 28.8 
No 178 71.2 
Total 250 100.0 
 
DISTRIBUTION OF THE STUDY SUBJECTS ACCORDING TO EXERCISE-
INDUCED ASTHMA: 
About 30% of the study subjects had exercise-induced asthma. They had 
developed exacerbation of asthma symptoms in some form of exertion in their day-to-
day activities. 
Table 20: Distribution of the study subjects according to  
Exercise-induced asthma (n=250) 
Exercise-induced asthma Frequency Percent 
Yes 74 29.6 
No 176 70.4 
Total 250 100.0 
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DISTRIBUTION OF THE STUDY SUBJECTS ACCORDING TO 
KNOWLEDGE ABOUT THE DIAGNOSIS: 
About 77% of the study subjects had knowledge about diagnosis. Majority of the 
patients were aware of their nature of disease and how it had been diagnosed. 
Table 21: Distribution of the study subjects according to  
Knowledge about the diagnosis (n=250) 
Knowledge about diagnosis Frequency Percent 
Yes 192 76.8 
No 58 23.2 
Total 250 100.0 
 
DISTRIBUTION OF THE STUDY SUBJECTS ACCORDING TO 
KNOWLEDGE ABOUT THE MODE OF TREATMENT: 
All the study subjects had knowledge about asthma. Almost all the patients 
were well aware of the mode of treatment they are undergoing. 
Table 22: Distribution of the study subjects according to  
Knowledge about the mode of treatment (n=250) 
Knowledge about asthma Frequency Percent 
Yes 250 100.0 
No 0 0 
Total 250 100.0 
 
63 
 
DISTRIBUTION OF THE STUDY SUBJECTS ACCORDING TO MODE OF 
TREATMENT: 
In our study majority of the subjects 205(82%) were on both oral drugs and inhalational 
drugs and remaining 45 subjects were taking only oral drugs. 
Table 23: Distribution of the study subjects according to  
Mode of treatment (n=250) 
Mode of treatment Frequency Percent 
Oral drugs only 45 18 
Oral drugs+Inhalational 
(LABA+ICS) 
205 82 
Total 250 100.0 
 
 
Fig 35: Distribution of the study subjects according to  
Mode of treatment (n=250) 
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DISTRIBUTION OF THE STUDY SUBJECTS ACCORDING TO 
SYMPTOMATIC CONTROL: 
About 75% of the study subjects had symptomatic control. Among the subjects 
who were undergoing various methods of treatment as out patients, majority of the 
patients had optimal control of symptoms. 
Table 24: Distribution of the study subjects according to  
Symptomatic control (n=250) 
Symptomatic control Frequency Percent 
Yes 188 75.2 
No 62 24.8 
Total 250 100.0 
 
 
Fig 36: Distribution of the study subjects according to  
Symptomatic control (n=250) 
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DISTRIBUTION OF THE STUDY SUBJECTS ACCORDING TO ABSOLUTE 
EOSINOPHILIC COUNT: 
About 72% of the study subjects had elevated absolute eosinophilic count. This 
clearly reflects major proportion of the prevalence of atopy and allergic type asthma 
among the individuals living in urban population. 
Table 25: Distribution of the study subjects according to  
Absolute eosinophilic count (AES) (n=250) 
AEC Frequency Percent 
Normal 69 27.6 
Elevated (>350) 181 72.4 
Total 250 100.0 
 
 
Fig 37: Distribution of the study subjects according to  
Absolute eosinophilic count (n=250) 
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DISTRIBUTION OF THE STUDY SUBJECTS ACCORDING TO SPUTUM 
CYTOLOGY: 
About 73% of the study subjects had eosinophilic cytology while 19% and 
roughly 8% of the study subjects had neutrophilic and mixed neutrophilic and 
eosinophilic type, respectively. 
Table 26: Distribution of the study subjects according to  
Sputum cytology (n=250) 
Sputum cytology Frequency Percent 
Eosinophilic 182 72.8 
Neutrophilic 47 18.8 
Mixed neutrophilic and 
eosinophilic  
19 7.6 
Pauci-granulocytic 2 0.8 
Total 250 100.0 
 
 
Fig 38: Distribution of the study subjects according to  
Sputum cytology (n=250) 
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DISTRIBUTION OF THE STUDY SUBJECTS ACCORDING TO ASTHMA 
PHENOTYPE: 
About 73% of the study subjects were of allergic phenotype while 15% and 8% of the 
study subjects had smoking related asthma and asthma with obesity, respectively. 
Table 27: Distribution of the study subjects according to  
Asthma phenotype (n=250) 
Asthma phenotype Frequency Percent 
Allergic phenotype 182 72.8 
Asthma with obesity 20 8.0 
Aspirin intolerant asthma 10 4.0 
Smoking related asthma 38 15.2 
Total 250 100.0 
 
 
Fig 39: Distribution of the study subjects according to  
Asthma phenotype (n=250) 
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DISTRIBUTION OF THE STUDY SUBJECTS ACCORDING TO AGE AND 
ASTHMA PHENOTYPE: 
The subjects with allergic phenotype have a low mean age in comparison to non-
allergic phenotype (29 years vs 41 years) and this difference in mean age was 
statistically significant. 
Table 28: Distribution of the study subjects according to  
Age and asthma phenotype (n=250) 
 
Allergic phenotype 
Non-Allergic 
phenotype Mean 
differenc
e 
Student 
‘t’ test p 
value 
Mean 
Standard 
Deviation 
Mean 
Standard 
Deviation 
AGE 29.47 9.15 41.09 6.37 -11.621 <0.001 
 
 
Fig 40: Distribution of the study subjects according to 
 Age and asthma phenotype (n=250) 
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DISTRIBUTION OF THE STUDY SUBJECTS ACCORDING TO GENDER 
AND ASTHMA PHENOTYPES: 
The subjects with allergic phenotype are mostly females in comparison to non-allergic 
phenotype (65% vs 26%) and this difference in gender distribution was statistically 
significant. 
Table 29: Distribution of the study subjects according to 
 Gender and asthma phenotypes (n=250) 
SEX 
Allergic Phenotype Non-Allergic Phenotype 
N % N % 
Male 64 35.20% 50 73.50% 
Female 118 64.80% 18 26.50% 
Total 182 100.0% 68 100.0% 
 
Chi-square value: 29.372      df =1  p value= <0.001* 
 
Fig 41: Distribution of the study subjects according to  
Gender and asthma phenotypes (n=250) 
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DISTRIBUTION OF THE STUDY SUBJECTS ACCORDING TO ASTHMA 
PHENOTYPE AND BODY MASS INDEX: 
The subjects with non-allergic phenotype had higher prevalence of overweight 
and obesity in comparison to allergic phenotype and this difference was statistically 
significant. 
Table 30: Distribution of the study subjects according to asthma phenotype and 
Body mass index (n=250) 
BMI 
Allergic Phenotype Non-Allergic Phenotype 
N % N % 
Normal 118 64.8% 27 39.7% 
Overweight 56 30.8% 31 45.6% 
Obese 8 4.4% 10 14.7% 
Total 182 100.0% 68 100.0% 
 
Chi-square value: 15.823     df =2 p value= <0.001* 
 
Fig 42: Distribution of the study subjects according to asthma phenotype and 
body mass index (n=250) 
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DISTRIBUTION OF THE STUDY SUBJECTS ACCORDING TO ASTHMA 
PHENOTYPES AND BIRTH ORDER: 
The subjects with allergic phenotype are mostly similar in comparison to non-
allergic phenotype in terms of birth order (57% vs 43%). 
Table 31: Distribution of the study subjects according to asthma phenotypes and 
Birth order (n=250) 
Birth 
order 
Allergic Phenotype Non-Allergic Phenotype 
N % N % 
1st order 123 67.6% 39 57.4% 
2nd order 
and above 
59 32.4% 29 42.6% 
Total 182 100.0% 68 100.0% 
 
Chi-square value: 2.271     df =1 p value= 0.132 
 
Fig 43: Distribution of the study subjects according to asthma phenotypes and 
Birth order (n=250) 
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DISTRIBUTION OF THE STUDY SUBJECTS ACCORDING TO AGE OF 
ONSET AND ASTHMA PHENOTYPE: 
The subjects with allergic phenotype had mostly early onset in comparison to 
non-allergic phenotype (87% vs 47%) and this difference was statistically significant. 
Table 32: Distribution of the study subjects according to  
Age of onset and asthma phenotype (n=250) 
Age of 
onset 
Allergic Phenotype Non-Allergic Phenotype 
N % N % 
Early 
onset 
159 87.4% 32 47.1% 
Late 
onset 
23 12.6% 36 52.9% 
Total 182 100.0% 68 100.0% 
 
Chi-square value: 44.599     df =1 p value= <0.001* 
 
Fig 44: Distribution of the study subjects according to  
Age of onset and asthma phenotype (n=250) 
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DISTRIBUTION OF THE STUDY SUBJECTS ACCORDING TO HISTORY 
OF ATOPY AND ASTHMA PHENOTYPE: 
The subjects with allergic phenotype had high proportion of atopy in comparison to 
non-allergic phenotype (72% vs 4%) and this difference was statistically significant. 
Table 33: Distribution of the study subjects according to  
History of atopy and asthma phenotype (n=250) 
History of 
atopy 
Allergic Phenotype Non-Allergic Phenotype 
N % N % 
Present 132 72.5% 3 4.4% 
Absent 50 27.5% 65 95.6% 
Total 182 100.0% 68 100.0% 
 
Chi-square value: 92.466     df =1 p value= <0.001* 
 
Fig 45: Distribution of the study subjects according to  
History of atopy and asthma phenotype (n=250) 
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DISTRIBUTION OF THE STUDY SUBJECTS ACCORDING TO 
HEREDITARY HISTORY AND ASTHMA PHENOTYPE: 
The subjects with allergic phenotype had high proportion of inheritance in the 
family in comparison to non-allergic phenotype (64% vs 12%) and this difference was 
statistically significant. 
Table 34: Distribution of the study subjects according to  
Hereditary history and asthma phenotype (n=250) 
Inheritance 
Allergic Phenotype Non-Allergic Phenotype 
N % N % 
Hereditary 117 64.3% 8 11.8% 
Non 
hereditary 
65 35.7% 60 88.2% 
Total 182 100.0% 68 100.0% 
 
Chi-square value: 54.622     df =1 p value= <0.001* 
 
Fig 46: Distribution of the study subjects according to  
Hereditary history and asthma phenotype (n=250) 
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DISTRIBUTION OF THE STUDY SUBJECTS ACCORDING TO HISTORY 
OF RECURRENT RESPIRATORY TRACT INFECTIONS (RRTI) AND 
ASTHMA PHENOTYPE: 
The subjects with allergic phenotype had high proportion of recurrent respiratory 
tract infections in comparison to non-allergic phenotype (82% vs 3%) and this 
difference was statistically significant. 
Table 35: Distribution of the study subjects according to  
History of RRTIs and asthma phenotype (n=250) 
H/o RRTI 
Allergic Phenotype Non-Allergic Phenotype 
N % N % 
Yes 149 81.9% 2 2.9% 
No 33 18.1% 66 97.1% 
Total 182 100.0% 68 100.0% 
 
Chi-square value: 128.93     df =1 p value= <0.001* 
 
Fig 47: Distribution of the study subjects according to  
History of RRTIs and asthma phenotype (n=250) 
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DISTRIBUTION OF THE STUDY SUBJECTS ACCORDING TO 
SUSCEPTIBILITY TO WEATHER CHANGES AND ASTHMA PHENOTYPE: 
The subjects with allergic phenotype had high proportion of susceptibility to 
weather change in comparison to non-allergic phenotype (82% vs 40%) and this 
difference was statistically significant. 
Table 36: Distribution of the study subjects according to susceptibility to  
Weather change and asthma phenotype (n=250) 
Weather 
changes 
Allergic Phenotype Non-Allergic Phenotype 
N % N % 
Susceptible 149 81.9% 27 39.7% 
Not 
susceptible 
33 18.1% 41 60.3% 
Total 182 100.0% 68 100.0% 
 
Chi-square value: 42.230     df =1 p value= <0.001* 
 
Fig 48: Distribution of the study subjects according to susceptibility to  
Weather change and asthma phenotype 
81.90%
39.70%
18.10%
60.30%
0.00%
10.00%
20.00%
30.00%
40.00%
50.00%
60.00%
70.00%
80.00%
90.00%
% %
ALLERGIC PHENOTYPE NON-ALLERGIC PHENOTYPE
CHANGE IN WEATHER AND ASTHMA PHENOTYPES
Susceptible Not susceptible
77 
 
DISTRIBUTION OF THE STUDY SUBJECTS ACCORDING TO ABSOLUTE 
EOSINOPHIL COUNT (AEC) AND ASTHMA PHENOTYPE: 
The subjects with allergic phenotype had high mean absolute eosinophil count 
in comparison to non-allergic phenotype (587 vs 231) and this difference in mean 
absolute eosinophil count was statistically significant. 
Table 37: Distribution of the study subjects according to  
Absolute eosinophil count and asthma phenotype (n=250)  
 
Allergic phenotype Non-Allergic phenotype 
Mean 
differenc
e 
Student 
‘t’ test p 
value 
Mean 
Standard 
Deviation 
Mean 
Standard 
Deviation 
AEC 587.03 155.382 231.47 70.927 355.56 <0.001 
 
 
Fig 49: Distribution of the study subjects according to  
Absolute eosinophil count and asthma phenotype (n=250)  
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DISTRIBUTION OF THE STUDY SUBJECTS ACCORDING TO MODE OF 
TREATMENT AND ASTHMA PHENOTYPE: 
In our population, almost all patients were consuming oral medications on a 
regular basis. Delineation of patients taking inhalational drugs alone could not be made 
out. This is mainly due to the low socioeconomic status, poor literacy and lack of 
knowledge of the disease they continue to demand for oral drugs. But it has been found 
that majority of the subjects with allergic phenotype 150(60%) taking inhalational 
(controller medications) with oral had better response to treatment than oral drugs only.  
Table 38: Distribution of the study subjects according to  
Mode of treatment and asthma phenotype (n=250) 
Mode of treatment 
Allergic 
phenotype 
Non-Allergic 
phenotype 
Total 
Oral Drugs only (%) 32 (12.8%) 13 (19.1) 45 (18.0%) 
Oral Drugs+Inhalational 
(LABA+ICS) (%) 
150 (60%) 55 (22.0%) 205 (82%) 
Total (%) 182 68 250 (100%) 
 
Chi-square value: 140.30     df =3 p value= <0.001* 
 
Fig 50: Distribution of the study subjects according to  
Mode of treatment and asthma phenotype (n=250) 
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DISTRIBUTION OF THE STUDY SUBJECTS ACCORDING TO SYMPTOM 
CONTROL AND ASTHMA PHENOTYPE: 
The subjects with allergic phenotype had high proportion of symptom control 
in comparison to non-allergic phenotype (96% vs 59%) and this difference was 
statistically significant. 
Table 39: Distribution of the study subjects according to  
Symptom control and asthma phenotype (n=250) 
Symptom 
control 
Allergic Phenotype Non-Allergic Phenotype 
N % N % 
Achieved 175 96.2% 40 58.8% 
Not 
achieved 
7 3.8% 28 41.2% 
Total 182 100.0% 68 100.0% 
 
Chi-square value: 57.298     df =1 p value= <0.001* 
 
Fig 51: Distribution of the study subjects according to  
Symptomatic control and asthma phenotype (n=250) 
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DISCUSSION 
Age distribution of study population: 
The age distribution in our study population ranged from 10-56 years. The mean 
age is 32.63. The number of patients in the age group 10-20, 21-30, 31-40, 41-50 and 
51-60 were 31(12.4%), 84(33.6%), 78(31.2%), 50(20%) and 7(2.8%) respectively. 
About 65% of the study subjects were in the age group of 21 to 40 years which denotes 
a higher prevalence of asthma in 2nd and 3rd decade of life which is usually documented 
in literature. When comparing the age with asthma phenotypes, the subjects with 
allergic phenotype have a low mean age in comparison to non-allergic phenotype (29 
years vs 41 years) and this difference in mean age (-11.621; Student ’t’ test p 
value,0.001) was statistically significant.  
Gender distribution of the study population: 
 Out of 250 study subjects, males were 114(45.6%) and females were 
136(54.4%). The subjects with allergic phenotype are mostly females in comparison to 
non-allergic phenotype (65% vs 26%) and this difference in gender distribution was 
statistically significant (chi-square value: 29.372, P,0.001).  
Distribution of study subjects according to the level of education: 
 Among the total number of 250 subjects included in our study only 88 (35.2%) 
were literates and 162 (64.8%) were illiterates. Though asthma is more prevalent among 
literates as proved by various studies, our study shows high prevalence of asthma among 
illiterates. This may be a limitation in our study due to the demographic influence in 
our study population. 
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Distribution of the study subjects according to socio-economic status: 
 Among the total number of 250 subjects included in our study, 160 (64%) 
subjects were classified under low socio-economic status according to modified 
Kuppuswamy scale and 90 (36%) subjects were classified under middle socio economic 
status. None of the study subjects were under high socio-economic status. Although 
asthma is considered as a disease of westernised population, it is more prevalent among 
the low socio-economic groups in our study. This may be a limitation in our study due 
to the demographic influence in our study population. 
Distribution of study subjects according to body mass index: 
 The subjects were classified according to body mass index, we found that the 
number of subjects belonged to normal, overweight and obese were 145 (58%), 87 
(34%) and 18 (7.2%) respectively. The subjects with non-allergic phenotype are having 
a higher prevalence of overweight and obesity (Chi-square value: 15.823; P<0.001) in 
comparison to allergic phenotype and this difference was statistically significant. 
Mostly asthma with obesity were females, late onset symptoms, less atopy and less 
significant hereditary pattern. Hence asthma with obesity is considered as a separate 
phenotype. 
Distribution of study subjects according to birth order: 
 Out of 250 subjects included in our study, 162(64.8%) subjects were first born 
children in their families and 88 (35.2%) subjects were belonged to higher birth order 
i.e. 2nd and above. When comparing the birth order with asthma phenotypes, the 
prevalence of asthma is high in the first born children (Chi-square value: 2.271; 
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P=0.132) irrespective of the phenotypes. But it was found to be statistically 
insignificant. This may be due to a small sample size of our study. 
Distribution of study subjects according to age of onset: 
 About 191 (76.4%) subjects of the study population had developed asthma at an 
early age i.e. before the age of 40 years and 59 (23.6%) subjects had developed their 
symptoms late in their life i.e. 40 years and above. When comparing the age of onset of 
asthma symptoms and the asthma phenotypes, the subjects with allergic phenotype had 
mostly early onset in comparison to non-allergic phenotype (87% vs 47%) and this 
difference was statistically significant with Chi-square value of 44.599 and P 
value<0.001. Since they possess distinct clinical features and management strategies 
they are considered as a separate phenotype in asthma.  
Distribution of study subjects according to history of smoking: 
 All females in our study group are non-smokers. This may be due to the fact that 
our population had not yet exposed to the westernized culture. Among the total males, 
52 patients (20.8%) were non-smokers and 62 (24.8%) were smokers. The patients with 
history of smoking were predominantly in the older age group and are associated with 
decreased blood eosinophilia.  
Distribution of study subjects according to the exposure of passive smoking: 
 Considering the children and female subjects, who had asthmatic symptoms, 111 
(44.4%) patients had given positive history of exposure to second hand smoking. This 
is considerably high when compared to the prevalence found in previous literatures. 
This shows high proportion of females and children also had passive smoking as a 
triggering factor for the worsening of asthma symptoms. 
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Distribution of study subjects according to history of atopy: 
 Among 250 patients included in our study, 132 (52.8%) subjects had history of 
atopy and 118 (47.2%) patients had no history of atopy. Subjects with allergic 
phenotype had high proportion of atopy in comparison to non-allergic phenotype (72% 
vs 4%) and this difference was statistically significant (Chi-square value: 92.466; 
P<0.001) which is usually documented in the literatures. The presence of atopy to food 
products, animal products, environmental dust and pollen dust were 52 (20.8%), 
33(13.2%), 31(12.4%), and 16(6.4%) respectively.  
Distribution of study subjects according to the hereditary pattern of asthma: 
 Among the 250 patients included in our study, 129 (51.6%) patients had given 
positive history for the presence of asthma in family members and 121 (48.4%) patients 
did not have a positive history of asthma in family. Out of 129 patients, positive history 
of asthma in mother, father and both were 76 (30.4%), 41 (16.4%) and 12 (4.8%) 
respectively. Subjects with allergic phenotype had increased prevalence of asthma in 
their family members in comparison to non-allergic phenotype (64% vs 12%) and this 
difference was statistically significant (Chi-square value: 54.622; P<0.001). The 
inheritance from mothers is high than fathers and this difference was also statistically 
significant (Chi-square value: 59.779; P<0.001). 
Distribution of study subjects according to history of exposure to aspirin: 
 Among the 250 patients included in our study, 16 patients had given positive 
history of increase in the asthmatic attacks after the ingestion of aspirin or other non-
steroidal anti-inflammatory drugs. They do not show any history of atopy or family 
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history of asthma. This prevalence is usually documented in literatures. Due to its 
specific characteristics of asthma pattern they are considered as a separate phenotype. 
Distribution of study subjects according to family size: 
 Out of 250 subjects, 158 (63.2%) patients were living in a small family and 92 
(36.8%) patients were living in a large family. Subjects with non-allergic phenotype 
belonged to high proportion of small family size in comparison to allergic phenotype 
(76% vs 58%) and this difference was statistically significant (Chi-square value: 7.073; 
P=0.008). 
Distribution of the study subjects according to history of recurrent 
respiratory infections (RRTI): 
 Out of 250 subjects, history of recurrent respiratory tract infections was 
positive in 151 (60.4%) subjects. Subjects with allergic phenotype had high proportion 
of recurrent respiratory tract infections in comparison to non-allergic phenotype (82% 
vs 3%; Chi-square value-128.93; P<0.001) and this difference was statistically 
significant.  
Distribution of the study subjects according to susceptibility to weather 
changes: 
 Out of 250 subjects, 176 (70.4%) were susceptible to develop asthma 
symptoms due to weather changes. Subjects with allergic phenotype had increased 
susceptibility to weather changes in comparison to non-allergic phenotype (80% vs 
40%; Chi-square value-42.230; P<0.001) and this difference was statistically 
significant. 
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Distribution of study subjects according to history of GERD: 
 Out of 250 patients, 47 (18.8%) patients were suffering from gastro-oesophageal 
reflux disorder. Most of the subjects are elderly females and with increased BMI. Hence 
GERD plays a role in the exacerbation of symptoms. 
Distribution of study subjects according to susceptibility to stress to develop 
asthma: 
 Among the 250 patients, 72 (28.8%) patients had symptoms susceptible 
secondary to stress or emotional liability. This reflects the amount of stress undergone 
by the urban population which acts as a trigger for asthma symptoms. 
Distribution of study subjects according to the knowledge of diagnosis and 
mode of treatment: 
Out of 250 subjects, patients taking only oral drugs were 45 (18.0%) and both 
oral with inhalational (LABA+ICS) were 205 (82.0%).  This is mainly due to the low 
socioeconomic status, poor literacy and lack of knowledge of the disease they continue 
to demand for oral drugs. Among 182 subjects of allergic phenotype, symptom control 
was achieved in 175 (96.2%). Among 68 subjects of non-allergic phenotype, symptom 
control was achieved in 40 (58.8%). Subjects with allergic phenotype had high 
proportion of symptomatic control in comparison to non-allergic phenotype (96% vs 
59%) and this difference was statistically significant (Chi-square value-57.298; 
P<0.001). 
Distribution of the study subjects according to absolute eosinophil count: 
 Among the 250 patients, 181 (72.4%) patients had elevated absolute eosinophil 
count. Absolute eosinophil count is the indirect measure of susceptibility of the subjects 
to atopy and it has been found that these subjects with allergic phenotype has high mean 
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absolute eosinophil count in comparison to non-allergic phenotype (587 vs 231) and 
this difference in mean absolute eosinophil count was statistically significant (Mean 
Difference-355.56; P<0.001). 
Distribution of the study subjects according to sputum cytology: 
 Out of 250 patients, the total number of patients classified under eosinophilic, 
neutrophilic, mixed neutrophilic and eosinophilic and Pauci-granulocytic were 
182(72.8%), 47(18.8%), 19(7.6%) and 2(0.8%) respectively. This reflects the high 
proportion of patients with allergic phenotype had predominantly eosinophilic sputum 
cytology which is usually documented in the literature as the cellular phenotypes of 
asthma. 
Distribution of study subjects according to the clinical asthma phenotypes: 
 Among the 250 subjects included in our study, four distinct clinical phenotypes 
were allergic 182(72.8%), asthma with obesity 20(8.0%), aspirin evoked 10(4.0%) and 
smoking related 38(15.2%) were found. In our study it is clearly evident that major 
proportion of the study subjects had elevated AEC and high sputum eosinophilia which 
shows high prevalence of atopy among the individuals living in the urban area who are 
constantly exposed to high amount of environmental air pollution. 
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CONCLUSION 
 Phenotyping of asthma serves as a stepping stone toward the practice of 
personalised treatment for asthma. 
 Recent treatment guidelines are aimed at reversing the bronchospasm with 
SABA and LABA and decreasing the  airway inflammation with ICS would help 
to achieve asthma control among the allergic phenotypes only  
 The treatment of asthma based on phenotype would reduce the likelihood of 
prescribing wrong drugs to wrong patients. It will also decrease the number of 
“difficult to treat” asthmatics and minimising the burden of this chronic 
heterogeneous inflammatory disease in a community. 
 Although asthma is a disease of westernised population as proved by various 
studies, our study concludes that asthma is a disease of all irrespective of socio-
economic status. 
 Hence untangling asthma phenotypes is a right direction towards a tailored 
management of asthma. 
 
 
 
 
 
 
 
88 
 
BIBLIOGRAPHY 
1. Global initiative for asthma 2015, www.ginasthma.org, 2015, 2-4. 
2. Global initiative for asthma 2016, www.ginasthma.org, 2016. 
3. Data from the 2012 National Health Interview Survey as compiled by the Centres for 
Disease Control and Prevention on 3/5/2014 and posted at 
http://www.cdc.gov/asthma/nhis/2012/table4-1.htm. 
4. Aberg N: Familial occurrence of atopic disease: genetic versus environmental factors. 
Clin Exp Allergy 23(10):829–834, 1993. 
5. Aberg N, Sundell J, Eriksson B, et al: Prevalence of allergic diseases in 
schoolchildren in relation to family history, upper respiratory infections, and residential 
characteristics. Allergy 51(4):232–237, 1996. 
6. Ronmark E, Lundback B, Jonsson E, et al: Incidence of asthma in adults—report 
from the Obstructive Lung Disease in Northern Sweden Study. Allergy 52(11):1071–
1078, 1997. 
7. Burrows B, Halonen M, Lebowitz MD, et al: The relationship of serum 
immunoglobulin E, allergy skin tests, and smoking to respiratory disorders. J Allergy 
Clin Immunol 70(3):199–204, 1982. 
8. Burrows B, Martinez FD, Halonen M, et al: Association of asthma with serum IgE 
levels and skin-test reactivity to allergens. N Engl J Med 320(5):271–277, 1989. 
9. Sears MR, Burrows B, Flannery EM, et al: Relation between airway responsiveness 
and serum IgE in children with asthma and in apparently normal children. N Engl J Med 
325(15):1067–1071, 1991. 
89 
 
10. Simpson BM, Custovic A, Simpson A, et al: NAC Manchester Asthma and Allergy 
Study (NACMAAS): risk factors for asthma and allergic 
11. Sporik R, Holgate ST, Platts-Mills TA, et al: Exposure to house-dust mite allergen 
(Der p I) and the development of asthma in childhood. A prospective study. N Engl J 
Med 323(8):502–507, 1990. 
12. Peat JK, Tovey E, Toelle BG, et al: House dust mite allergens. A major risk factor 
for childhood asthma in Australia. Am J Respir Crit Care Med 153(1):141–146, 1996. 
13. Platts-Mills TA, Sporik R, Ingram JM, et al: Dog and cat allergens and asthma 
among school children in Los Alamos, New Mexico, USA: altitude 7,200 feet. Int Arch 
Allergy Immunol 107(1–3):301–303, 1995. 
14. Huss K, Adkinson NF Jr, Eggleston PA, et al: House dust mite and cockroach 
exposure are strong risk factors for positive allergy skin test responses in the Childhood 
Asthma Management Program. J Allergy Clin Immunol 107(1):48–54, 2001 disorders 
in adults. Clin Exp Allergy 31(3):391–399, 2001. 
15. Strachan DP: Hay fever, hygiene, and household size. BMJ 299(6710):1259–1260, 
1989. 
16. Riedler J, Braun-Fahrlander C, Eder W, et al: Exposure to farming in early life and 
development of asthma and allergy: a cross-sectional survey. Lancet 358(9288):1129–
1133, 2001. 
17. Klintberg B, Berglund N, Lilja G, et al: Fewer allergic respiratory disorders among 
farmers’ children in a closed birth cohort from Sweden. Eur Respir J 17(6):1151–1157, 
2001. 
18. Von Ehrenstein OS, Von Mutius E, Illi S, et al: Reduced risk of hay 
fever and asthma among children of farmers. Clin Exp Allergy 30(2):187–193, 2000 
90 
 
19. Penders J, Thijs C, van den Brandt PA, et al: Gut microbiota composition and 
development of atopic manifestations in infancy: the KOALA Birth Cohort Study. Gut 
56(5):661–667, 2007. 
20. Bjorksten B, Sepp E, Julge K, et al: Allergy development and the intestinal 
microflora during the first year of life. J Allergy Clin Immunol 108(4):516–520, 2001. 
21. Kalliomaki M, Kirjavainen P, Eerola E, et al: Distinct patterns of neonatal gut 
microflora in infants in whom atopy was and was not developing. J Allergy Clin 
Immunol 107(1):129–134, 2001. 
22. Vebo HC, Sekelja M, Nestestog R, et al: Temporal development of the infant gut 
microbiota in immunoglobulin E-sensitized and nonsensitized children determined by 
the GA-map infant array. Clin Vaccine Immunol 18(8):1326–1335, 2011. 
23. van Nimwegen FA, Penders J, Stobberingh EE, et al: Mode and place of delivery, 
gastrointestinal microbiota, and their influence on asthma and atopy. J Allergy Clin 
Immunol 128(5):948–955, e1–3, 2011. 
24. Oyama N, Sudo N, Sogawa H, et al: Antibiotic use during infancy promotes a shift 
in the T(H)1/T(H)2 balance toward T(H)2-dominant immunity in mice. J Allergy Clin 
Immunol 107(1):153–159, 2001. 
25. Noverr MC, Falkowski NR, McDonald RA, et al: Development of allergic airway 
disease in mice following antibiotic therapy and fungal microbiota increase: role of host 
genetics, antigen, and interleukin-13. Infect Immun 73(1):30–38, 2005. 
26. Hunt JR, Martinelli R, Adams VC, et al: Intragastric administration of 
Mycobacterium vaccae inhibits severe pulmonary allergic inflammation in a mouse 
model. Clin Exp Allergy 35(5):685–690, 2005. 
 
91 
 
27. Arnold IC, Dehzad N, Reuter S, et al: Helicobacter pylori infection prevents allergic 
asthma in mouse models through the induction of regulatory T cells. J Clin Invest 
121(8):3088–3093, 2011. 
28. Forsythe P, Inman MD, Bienenstock J: Oral treatment with live Lactobacillus 
reuteri inhibits the allergic airway response in mice. Am J Respir Crit Care Med 
175(6):561–569, 2007. 
29. Karimi K, Inman MD, Bienenstock J, et al: Lactobacillus reuteriinduced regulatory 
T cells protect against an allergic airway response in mice. Am J Respir Crit Care Med 
179(3):186–193, 2009? 
30. Atarashi K, Tanoue T, Shima T, et al: Induction of colonic regulatory T cells by 
indigenous Clostridium species. Science 331(6015):337–341, 2011. 
31. Hill DA, Siracusa MC, Abt MC, et al: Commensal bacteria-derived signals regulate 
basophil hematopoiesis and allergic inflammation. Nat Med 18(4):538–546, 2012. 
32. Herbst T, Sichelstiel A, Schar C, et al: Dysregulation of allergic airway 
inflammation in the absence of microbial colonization. Am J Respir Crit Care Med 
184(2):198–205, 2011. 
33. Weiss ST, Tager IB, Munoz A, et al: The relationship of respiratory infections in 
early childhood to the occurrence of increased levels of bronchial responsiveness and 
atopy. Am Rev Respir Dis 131(4):573–578, 1985. 
34. Sigurs N, Gustafsson PM, Bjarnason R, et al: Severe respiratory syncytial virus 
bronchiolitis in infancy and asthma and allergy at age 13. Am J Respir Crit Care Med 
171(2):137–141, 2005. 
35. Sigurs N, Aljassim F, Kjellman B, et al: Asthma and allergy patterns over 18 years 
after severe RSV bronchiolitis in the first year of life. Thorax 65(12):1045–1052, 2010. 
92 
 
36. Stein RT, Sherrill D, Morgan WJ, et al: Respiratory syncytial virus in early life and 
risk of wheeze and allergy by age 13 years. Lancet 354(9178):541–545, 1999. 
37. Stein RT: Long-term airway morbidity following viral LRTI in early infancy: 
recurrent wheezing or asthma? Paediatr Respir Rev 10(Suppl 1):29–31, 2009. 
38. Kusel MM, de Klerk NH, Kebadze T, et al: Early-life respiratory viral infections, 
atopic sensitization, and risk of subsequent development of persistent asthma. J Allergy 
Clin Immunol 119(5):1105–1110, 2007. 
39. Martin RJ, Kraft M, Chu HW, et al: A link between chronic asthma and chronic 
infection. J Allergy Clin Immunol 107(4):595–601, 2001. 
40. Johnston SL, Martin RJ: Chlamydophila pneumoniae and Mycoplasma 
pneumoniae: a role in asthma pathogenesis? Am J Respir Crit Care Med 172(9):1078–
1089, 2005. 
41. Schildcrout JS, Sheppard L, Lumley T, et al: Ambient air pollution and asthma 
exacerbations in children: an eight-city analysis. Am J Epidemiol 164(6):505–517, 
2006. 
42. McCreanor J, Cullinan P, Nieuwenhuijsen MJ, et al: Respiratory effects of exposure 
to diesel traffic in persons with asthma. N Engl J Med 357(23):2348–2358, 2007. 
43. Jerrett M, Shankardass K, Berhane K, et al: Traffic-related air pollution and asthma 
onset in children: a prospective cohort study with individual exposure measurement. 
Environ Health Perspect 116(10):1433–1438, 2008. 
44. Modig L, Toren K, Janson C, et al: Vehicle exhaust outside the home and onset of 
asthma among adults. Eur Respir J 33(6):1261–1267, 2009. 
93 
 
45. Morgenstern V, Zutavern A, Cyrys J, et al: Atopic diseases, allergic sensitization, 
and exposure to traffic-related air pollution in children. Am J Respir Crit Care Med 
177(12):1331–1337, 2008. 
46. Brauer M, Hoek G, Smit HA, et al: Air pollution and development of asthma, allergy 
and infections in a birth cohort. Eur Respir J 29(5):879–888, 2007. 
47. Gehring U, Wijga AH, Brauer M, et al: Traffic-related air pollution and the 
development of asthma and allergies during the first 8 years of life. Am J Respir Crit 
Care Med 181(6):596–603, 2010. 
48. Nishimura KK, Galanter JM, Roth LA, et al: Early-life air pollution and asthma risk 
in minority children. The GALA II and SAGE II 
studies. Am J Respir Crit Care Med 188(3):309–318, 2013. 
49. Toren K, Blanc PD: Asthma caused by occupational exposures is common—a 
systematic analysis of estimates of the populationattributable fraction. BMC Pulm Med 
9:7, 2009. 
50. Szefler SJ, Martin RJ, King TS, et al: Significant variability in response to inhaled 
corticosteroids for persistent asthma. J Allergy Clin Immunol 109(3):410–418, 2002. 
51. Martin RJ, Szefler SJ, King TS, et al: The Predicting Response to Inhaled 
Corticosteroid Efficacy (PRICE) trial. J Allergy Clin Immunol 119(1):73–80, 2007. 
52. Wenzel SE: Eosinophils in asthma—closing the loop or opening the door? N Engl 
J Med 360(10):1026–1028, 2009. 
53. Haldar P, Pavord ID: Noneosinophilic asthma: a distinct clinical and pathologic 
phenotype. J Allergy Clin Immunol 119(5):1043–1052, quiz 53–4, 2007. 
94 
 
54. Wenzel SE, Schwartz LB, Langmack EL, et al: Evidence that severe asthma can be 
divided pathologically into two inflammatory subtypes with distinct physiologic and 
clinical characteristics. Am J Respir Crit Care Med 160(3):1001–1008, 1999. 
55. Hastie AT, Moore WC, Meyers DA, et al: Analyses of asthma severity phenotypes 
and inflammatory proteins in subjects stratified by sputum granulocytes. J Allergy Clin 
Immunol 125(5):1028–1036, 
e13, 2010. 
56. Porsbjerg C, Lund TK, Pedersen L, et al: Inflammatory subtypes in asthma are 
related to airway hyperresponsiveness to mannitol and exhaled NO. J Asthma 
46(6):606–612, 2009. 
57. Haldar P, Pavord ID, Shaw DE, et al: Cluster analysis and clinical asthma 
phenotypes. Am J Respir Crit Care Med 178(3):218–224, 2008. 
58. Woodruff PG, Modrek B, Choy DF, et al: T-helper type 2-driven inflammation 
defines major sub-phenotypes of asthma. Am J Respir Crit Care Med 180(5):388–395, 
2009. 
59. Andre´a Lessard, He´le`ne Turcotte, et al: Obesity and Asthma* A Specific 
Phenotype? Chest. 2008; 134(2):317-323 
60. Beuther DA, Sutherland ER: Overweight, obesity, and incident asthma: a meta-
analysis of prospective epidemiologic studies. American journal of respiratory and 
critical care medicine. 2007 Apr 1; 175(7):661-6. 
61. Holguin F, Bleecker ER: Obesity and asthma: an association modified by age of 
asthma onset. Journal of Allergy and Clinical Immunology. 2011; 127(6):1486-93. 
95 
 
62. Camargo CA, Weiss ST, et al: Prospective study of body mass index, weight change, 
and risk of adult-onset asthma in women. Archives of Internal Medicine. 1999 Nov 22; 
159(21):2582-8. 
63. Tan DJ, Walters EH, Perret JL, et al: Age-of-asthma onset as a determinant of 
different asthma phenotypes in adults: a systematic review and meta-analysis of the 
literature. Expert review of respiratory medicine. 2015 Jan 2; 9(1):109-23. 
64. Sood A, Qualls C, Schuyler M, et al: Adult-onset asthma becomes the dominant 
phenotype among women by age 40 years. The longitudinal CARDIA study. Annals of 
the American Thoracic Society. 2013 Jun; 10(3):188-97. 
65. Miranda C, Busacker A, et al: Distinguishing severe asthma phenotypes: role of age 
at onset and eosinophilic inflammation. Journal of Allergy and Clinical Immunology. 
2004 Jan 31; 113(1):101-8.  
66. Siroux V, Curt F, et al: Role of gender and hormone-related events on IgE, atopy, 
and eosinophils in the Epidemiological Study on the Genetics and Environment of 
Asthma, bronchial hyper-responsiveness and atopy. Journal of allergy and clinical 
immunology. 2004 Sep 30; 114(3):491-8. 
67. London SJ, Gauderman WJ, et al: Family history and the risk of early onset 
persistent, early onset transient and late onset asthma. Epidemiology (Cambridge, 
Mass.). 2001 Sep; 12(5):577. 
68. Litonjua AA, Carey VJ, et al: Parental history and the risk for childhood asthma: 
does mother confer more risk than father? American journal of respiratory and critical 
care medicine. 1998 Jul 1; 158(1):176-81. 
96 
 
69. von MUTIUS ER, Nicolai T, et al: Familial aggregation of asthma in a South 
Bavarian population. American journal of respiratory and critical care medicine. 1996 
Apr; 153(4):1266-72. 
70. Lim RH, Kobzik L, et al: Risk for asthma in offspring of asthmatic mothers versus 
fathers: a meta-analysis. PLoS One. 2010 Apr 12; 5(4):e10134. 
71. Davis JB, Bulpitt CJ, et al: Atopy and wheeze in children according to parental 
atopy and family size. Thorax. 1981 Mar 1; 36(3):185-9. 
72. Goldberg S, Israeli E, et al: Asthma prevalence, family size, and birth order. CHEST 
Journal. 2007 Jun 1; 131(6):1747-52. 
73. Bernsen R, Jongste JC, et al: Birth order and sibship size as independent risk factors 
for asthma, allergy, and eczema. Paediatric allergy and immunology. 2003 Dec 1; 
14(6):464-9. 
74. Karmaus W, Botezan C: Does a higher number of siblings protect against the 
development of allergy and asthma? A review. Journal of epidemiology and community 
health. 2002 Mar 1; 56(3):209-17. 
75. Flodin U, Ponsson P, et al: An epidemiologic study of bronchial asthma and 
smoking. Epidemiology. 1995 Sep 1; 6(5):503-5. 
76. Siroux VI, Pin I, et al: Relationships of active smoking to asthma and asthma 
severity in the EGEA study. Epidemiological study on the Genetics and Environment 
of Asthma. European Respiratory Journal. 2000 Mar 1; 15(3):470-7. 
77. Stapleton M, Howard-Thompson A, et al: Smoking and asthma. The Journal of the 
American Board of Family Medicine. 2011 May 1; 24(3):313-22. 
97 
 
78. Verlato G, Nguyen G, et al: Smoking and New-Onset Asthma in a Prospective Study 
on Italian Adults. International Archives of Allergy and Immunology. 2016 Aug 18; 
170(3):149-57. 
79. Gilliland, Frank D, et al: Regular smoking and asthma incidence in 
adolescents. American journal of respiratory and critical care medicine174.10 (2006): 
1094-1100. 
80. Vally H, Taylor ML, et al: The prevalence of aspirin intolerant asthma (AIA) in 
Australian asthmatic patients. Thorax. 2002 Jul 1; 57(7):569-74. 
81. Jenkins C, Costello J, Hodge L. Systematic review of prevalence of aspirin induced 
asthma and its implications for clinical practice. British medical journal. 2004 Feb 19; 
328(7437):434. 
 
 
 
 
 
 
 
 
 
98 
 
LIST OF ABBREVIATIONS USED 
 
Th2  -Type 2 helper cells 
LRI  -Lower Respiratory Infections 
ICS  -Inhaled Corticosteroids 
IgE  -Immunoglobulin E 
BMI  -Body Mass Index 
SES  -Socio-economic status 
SHS  -Second Hand Smoke 
EGEA  -Epidemiological study on the genetics and environment of asthma 
NSAID -Non-steroidal anti-inflammatory drugs 
AIA  -Aspirin intolerant asthma 
GINA  -Global Initiative for Asthma 
COPD  -Chronic Obstructive Pulmonary Disease 
GERD -Gastro-oesophageal reflux disease 
AEC  -Absolute eosinophil count 
RRTI  -Recurrent respiratory tract infection 
SABA  -Short acting Beta 2 agonist 
LABA -Long acting Beta 2 agonist 
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PROFORMA 
PATIENT’S DEMOGRAPHY 
1. Serial No. 2. Date: 
3. Name:  
4. Age: 
5. Gender: 
6. Address:  
 
 
7. Phone: 
8. Religion: Hindu/Christian/Muslim/Others 
9. Habitat/Locality: Rural/Urban 
10. Level of education: literate/Illiterate 
11. Occupation:  __________________ 
  
12. Socio-economic status Low/Middle/Upper 
13. BMI Underweight (Below 18.5) 
 Normal (18.5-24.9) 
 Overweight (25.0-29.9) 
 Obese (30 and 
above) 
CHILDHOOD HISTORY 
14. Birth Order    ____________ 
15. Exposure to recurrent infection   RS/GIT 
16. Immunisation status    ____________ 
17. Exposure to Farm Products    Yes/No 
18. Exposure to Smoke    Yes/No 
RISK FACTORS/PREDISPOSING FACTORS 
19. Allergy/Atopy    Yes/No 
20. Hereditary    Yes/No    
       If yes    Mother/Father/Both 
    Grandparents 
    Siblings 
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CAUSAL FACTORS 
21. Exposure to allergens    Pollen dust/Environmental 
dust 
    Food products/Animals 
22. Exposure to chemicals in work place   Yes/No 
23. H/O drug intake    Yes/No 
       (Aspirin/NSAIDS) 
CONTRIBUTING FACTORS 
24. H/O Environmental Tobacco Smoke   Yes/No 
25. H/O Upper respiratory infection   Yes/No 
26. H/O Exposure to Air Pollution   Yes/No 
PROTECTING FACTORS 
27. Food habits    Veg/Non-Veg 
28. Habitation    Rural/Urban 
29. Family Size    Large/Small 
TRIGGERING FACTORS 
30. H/O Respiratory infection    Yes/No 
31. H/O GERD    Yes/No 
32. Change in weather conditions    Yes/No 
33. Pregnancy    Yes/no 
34. H/O Stress and Emotional conditions   Yes/No 
35. Whether exercise induced    Yes/No  
PATIENT’S KNOWLEDGE 
36. Knowledge about the disease    Yes/No 
37. Knowledge about the diagnosis   Yes/No 
      If Yes       Spirometry/Clinical 
38. Mode of treatment undertaken             __________ 
39. Knowledge about the treatment outcome  Yes/No 
40. Whether symptoms controlled    Yes/No 
41. Absolute eosinophil count    __________ 
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TURITIN ORIGINALITY CERTIFICATE 
 
